# Pharmacokinetic Study of 4 mg Nicotine Lozenge.

> **NCT01669122** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 40 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** nicotine

## Key facts

- **NCT ID:** NCT01669122
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669122, "Pharmacokinetic Study of 4 mg Nicotine Lozenge.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01669122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*